More Than Just Reproductive Health
The Women’s Health space is moving towards concentrating on the overall well-being of women throughout their entire life cycle, rather than their reproductive needs alone. Postmenopausal conditions, including Vulvovaginal Atrophy, that affect a woman’s quality of life are actively being fostered for innovation of new therapies and dosage forms. With the rapid growth of this therapeutic area, the competition to enter onto the market quickly is equally as present. This quickness can be hindered by restricting I/E criteria and variable endpoints. Unforeseen factors like these can lead to unexpected complications when running Women’s Health trials.
Treating Women’s Health Holistically
Biorasi’s history in successfully running women’s health trials covers the full spectrum of women’s lives. This experience allows Biorasi to identify and proactively mitigate any anticipated challenges, and include one of the many board certified OBGYNs in our site network for successful study completion. Biorasi is capable and ready to provide your next women’s health study with the time, attention, and tailored solutions it deserves.
"One of the rarest events, where we had to communicate [to Biorasi] to stop the screening rather than boost it."VP of Global Clinical Development, Top Specialty Pharma
Latest News and Blogs
Why is it that when we take 50 people of similar height and weight and measure their fasting blood glucose, we get 50 different results? Shouldn’t they be pretty much the same, since we are all humans? The answer to this may seem obvious, but a lot of science has been...
Mobile phone apps and wearable devices have a lot of potential to improve clinical studies. However, the rules governing them are complex, varied, and not fully developed. It is important to be vigilant and remember best practices before rushing out to jump on the...